Bayer AG annual net income
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Bayer AG Net Income Growth & History (BAYN)
Bayer AG's net income was −€3.60B for fiscal 2025.
View full Bayer AG company overviewBayer AG annual net income history
| Fiscal year | Period ended | Net income | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −€3.60B | −€1.05B | — |
| 2024 | 2024-12-31 | −€2.55B | €396.0M | — |
| 2023 | 2023-12-31 | −€2.94B | −€7.11B | — |
| 2022 | 2022-12-31 | €4.17B | €3.14B | +307.63% |
| 2021 | 2021-12-31 | €1.02B | €11.51B | — |
| 2020 | 2020-12-31 | −€10.49B | −€14.60B | — |
| 2019 | 2019-12-31 | €4.11B | €2.40B | +140.21% |
| 2018 | 2018-12-31 | €1.71B | −€6.38B | −78.86% |
| 2017 | 2017-12-31 | €8.09B | €3.27B | +67.72% |
| 2016 | 2016-12-31 | €4.83B | €728.0M | +17.76% |
| 2015 | 2015-12-31 | €4.10B | €655.0M | +19.02% |
| 2014 | 2014-12-31 | €3.44B | €257.0M | +8.07% |
| 2013 | 2013-12-31 | €3.19B | €690.0M | +27.64% |
| 2012 | 2012-12-31 | €2.50B | €24.0M | +0.97% |
| 2011 | 2011-12-31 | €2.47B | €1.16B | +88.70% |
| 2010 | 2010-12-31 | €1.31B | — | — |
Bayer AG quarterly net income
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Net income | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | €219.0M | €418.0M | — |
| Q1 2026 | 2026-03-31 | €2.76B | — | — |
| Q4 2025 | 2025-12-31 | −€3.76B | — | — |
| Q3 2025 | 2025-09-30 | −€963.0M | — | — |
| Q2 2025 | 2025-06-30 | −€199.0M | — | — |
Bayer AG net income trends
Over the last five fiscal years, Bayer AG's net income increased from −€10.49B to −€3.60B, a change of €6.89B. The latest reported quarter, Q2 2026, shows €219.0M.
About the metric
What net income means
Net income is a company’s bottom-line profit or loss after operating costs, interest, taxes, and other reported income and expenses. It shows how much of a company’s revenue ultimately remained as earnings, or how large its loss was, during a fiscal period.
Calculation and source
reported net income
TickerStat standardizes consolidated net income or profit and loss reported in company official filings for aligned fiscal periods. It is not adjusted earnings, an analyst estimate, or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bayer AG source filings ↗Community posts
Bayer wins the first Roundup trial following the Supreme Court ruling
A Missouri jury unanimously ruled for Bayer ($BAYN)’s Monsanto unit in a three-plaintiff Roundup case, rejecting design-defect, fraud and negligence claims. It was the first such trial following the US Supreme Court decision that blocked th ...
Bayer’s Nubeqa cuts risk of metastasis or death in prostate trial
Bayer ($BAYN) disclosed interim Phase 3 results showing that adding Nubeqa to hormone therapy and radiation reduced the risk of metastasis or death by 58% in prostate-cancer patients at high risk of recurrence. Four-year metastasis-free sur ...
